# Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer

> **NCT04758416** · — · UNKNOWN · sponsor: **Fudan University** · enrollment: 50 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** biopsy or surgical pathology in metastases
- **DRUG:** 68Ga-HER2 affibody,18F-FDG, 18F-FES

## Key facts

- **NCT ID:** NCT04758416
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-31
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04758416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04758416, "Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT04758416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*